Why I'm joining Prezent: An incredible opportunity to build the future of life sciences communications

Medical communications is changing fast. For years, our industry has relied on processes that simply cannot keep up with the pace of scientific discovery or the expectations of the audiences we serve. We need a new way to deliver the right content to the right people at the right moment.

That is why I am joining Prezent.

In my first conversation with Prezent's founder, Rajat Mishra, I was struck by his commitment to building solutions that truly empower people to communicate with clarity and confidence. That mission immediately aligned with my own. Throughout my career, I have been driven by one goal: helping experts communicate in ways that elevate their science and expand their reach and impact.

So when I learned about Prezent Vivo, a model that brings AI and human expertise together to transform how life sciences teams create and deliver communication, I knew this was the future our industry has been waiting for.

Prezent Vivo is not just about speed. It is about enabling teams to deliver communication that is scientifically strong, strategically sharp, and tailored to each audience. It is about pairing human insight with the power of AI so clarity scales, consistency strengthens, and great ideas travel further.

I am thrilled to lead Prezent Vivo and to help biopharma teams and agencies communicate in a way that finally keeps pace with the science: faster, smarter, and with greater impact. At the heart of it all is a mission I deeply believe in: advancing science by ensuring it is understood.

My professional journey: From science to strategic communication

My deep appreciation for the life sciences is rooted in both my academic training and the experiences that shaped me early in my career. I began with a PhD in Australia, which eventually led me to a three-year postdoctoral fellowship in New York City. After my postdoc, I joined ImClone Systems, a biotech company that was later acquired by Eli Lilly.

During that time, I realized something important about myself: my strengths were not limited to generating science, but in helping others truly understand it.

"My strength is taking complex science and making it land with every audience that needs to hear it."

That realization changed the trajectory of my career. It led me into medical communications at a large advertising holding company, where I built and led the scientific strategy team. My focus was simple but powerful: help clients tell their scientific story clearly, confidently, and in a way that genuinely reaches healthcare professionals, patients, and internal teams.

As my career evolved, I expanded into brand strategy, engagement strategy, and business development, supporting both large holding companies and private equity-backed organizations. No matter the role, the goal remained the same: strengthen how science is communicated so it can have the impact it deserves.

Across every chapter of my journey, one principle has stayed constant. Effective communication is not a “nice to have” in life sciences. It is the force that turns data into understanding, understanding into action, and action into better outcomes for the people we ultimately serve.

Major shifts in life science communication: AI's reshaping of the industry

After twenty years in medical communications, I have learned that our industry evolves in waves. Each wave reshapes how we translate science into understanding, and each one demands that we rethink how we work.

The first wave was all about building the scientific story. We focused on clarity, accuracy, and credibility, ensuring that complex data could be understood by specialists, community physicians, and patients alike. It was foundational work, and it set the stage for everything that followed.

The second wave pushed us toward modularity. We recognized that one-size-fits-all communication no longer worked. Audiences needed content tailored to their level of expertise, their context, and their needs. The industry shifted toward creating core scientific narratives that could be adapted and personalized.  At Prezent Vivo, we refer to this as matching content to each audience’s unique fingerprint.

Now we are entering the third wave, and it is the most transformative one yet: the AI-enabled era of life science communication.

AI is not simply a new tool. It is reshaping how quickly we can absorb information, generate insights, and deliver communication that keeps pace with the science. It is changing expectations, accelerating timelines, and redefining what excellence looks like.

But speed alone is not the story.

Life sciences demand rigor, responsibility, and nuance. The opportunity ahead is not about replacing human expertise; it’s about amplifying it. AI can take on the heavy lift of processing, structuring, and scaling information, while human experts bring the scientific judgment, strategic insight, and empathy that ensure communication is accurate, ethical, and impactful.

The future of Med Comms is a partnership between AI and human expertise that elevates the work we do and expands the impact we can have.

And for the first time, we have the tools to deliver communication that truly keeps up with the speed of science.

The challenges holding the industry back

Communication in the field of Life Sciences carries real responsibility. It influences how information is understood and how decisions are made. Poor communication can introduce bias, delay critical information, and create compliance risks. In some cases, it can directly impact patient outcomes.

Despite tremendous scientific progress, life science communication is still constrained by outdated systems. The volume and complexity of data have grown dramatically, yet many teams are still using manual, linear processes that cannot keep pace. Content development remains fragmented across functions, creating duplication, inconsistent messaging, and delays.

Personalization is also difficult to achieve at scale, leaving many audiences with communication that does not fully meet their needs. And while accuracy and compliance are essential, the processes designed to protect quality often slow teams down even further.

These challenges are not about capability. They are about infrastructure. The industry is ready to move faster, but the tools and workflows of the past are holding it back.

Biopharma and agency struggles 

Biopharma is under constant pressure to deliver more with fewer resources. Budgets are tightening, expectations for speed are rising, and the volume of clinical data continues to grow. Translating insights quickly and accurately has become increasingly difficult.

Agencies face a different but equally demanding reality. They must manage an expanding workload under compressed timelines while navigating evolving regulatory requirements. The result is teams stretched across competing priorities, often without the tools or time they need to operate at their best.

The persistent bottleneck of communicating complex science 

One challenge that continues to hold the industry back is the ability to translate strong scientific ideas into clear, effective communication across formats and audiences.

"You can have great ideas, you can have great scientific content, but if you are bogged down in putting that information in a format that can be effectively communicated... you can't do great work."

Whether it is a presentation, a scientific poster, a report, or an internal communication, the challenge remains the same. Complex ideas need to be simplified, structured, and tailored so that each audience can understand and act on them.

This is where teams often slow down. Even when the science and strategy are strong, significant time is spent aligning content, adapting it for different audiences, and ensuring it is communicated in a clear and consistent way.

Limitations of traditional agency models

The traditional model of medical communications is not built for the pace or scale of today’s life sciences environment.

"The traditional model of delivering medical communications is fundamentally outdated."

Layers of review, editorial checkpoints, and manual production steps consume significant time and energy. As a result, highly skilled scientific and strategic experts spend less time applying the intellectual value of their expertise and more time navigating tedious, repetitive production tasks.

The model is straining under the weight of modern demands, and it is no longer enough for the speed at which science now moves.

Where general AI falls short

General-purpose AI platforms are powerful, but they introduce serious risks when applied to life sciences communication. 

Life sciences organizations work with highly confidential data, and open platforms raise unavoidable concerns around data security and potential exposure.  These tools also lack production-level accuracy. They are not built to consistently align with brand guidelines, regulatory requirements, or the nuanced needs of different audiences.

Beyond that, generic AI has a limited strategic context. It can generate content, but it does not understand the deeper scientific, medical, or behavioral insights required for effective communication in this field. Ultimately, AI falls short on integrity. It cannot apply the humanistic and strategic lens that sensitive medical content demands. 

"I got so excited about some of the output I was originally getting. And then I spent four or five hours fixing it. Until they accomplish what Prezent has accomplished, combining AI with human expertise for rigor and brand compliance, you cannot rely on them exclusively."

In life sciences, poor communication has real consequences. It can lead to regulatory risk and ultimately impact the decisions patients and healthcare professionals make. This is why the industry needs AI that is purpose-built, compliant, and grounded in scientific and strategic rigor.

Why I chose Prezent

When I first learned about Prezent, my reaction was immediate and honest: "Where have you been all of my career?"

For twenty years, I had been dreaming of exactly this. A purpose-built, slide-sorting, and overnight solution designed to relieve the unique pressures of life sciences. Prezent finally built what the industry has needed all along.

Prezent Vivo: a new model for life sciences

One of the key reasons I chose Prezent Vivo is it’s a model that fuses AI and human expertise into one integrated experience rather than treating them as a tradeoff.

At its core, Prezent Vivo focuses on simplifying the production layer of communication. Using purpose-built AI to handle formatting, alignment, and brand consistency from the start, it allows teams to move faster without sacrificing quality.

This shift is important because it frees up experts to focus on what truly requires human judgment, including scientific accuracy, regulatory nuance, and strategic storytelling.

Prezent Vivo is built to meet the pace and complexity of modern life sciences communication. Teams no longer have to choose between speed and rigor. They can deliver communication that is timely, compliant, and grounded in strong scientific thinking, whether they sit within a biopharma organization or a medical communications agency.

The importance of human expertise

In a market as regulated and risk-sensitive as life sciences, pairing AI with human expertise is not optional.  It is essential. General-purpose AI does not understand the nuances of a product, its history, or the strategic intent behind a team's communication plan.

"We can’t rely entirely on a machine. We always need to have that human lens when it comes to communicating such critical life science information.”

AI can accelerate processes, but it cannot replace judgment, experience, or the deep audience understanding required in this field. Prezent Vivo enables the right balance by taking on the repetitive, time-consuming aspects of communication and freeing experts to focus on what truly matters: applying strategic insight, ensuring scientific integrity, and shaping communication that is accurate, responsible, and meaningful for every audience.

The future of life science communication

Looking ahead five to ten years, I see AI transforming how we uncover and apply insights, and communicate that intelligence effectively to multiple audiences. Instead of spending hours or days processing raw information, teams will be able to move directly into interpretation and strategy. AI will synthesize data from clinical study reports, advisory boards, and market research, allowing human experts to focus on the thinking that truly drives impact.

My vision is for Prezent Vivo to become the communication partner of choice for the entire life sciences ecosystem. A solution that is synonymous with medical communications, whether you sit within a biopharma organization or a medical communications agency.

"I hope that in five or ten years, Prezent Vivo will be seen as the communication partner the industry has been seeking. Acting as the life sciences partner that can turn around brilliant presentations that make our clients incredibly effective."

Ultimately, this is about fusing AI with human expertise. By giving life sciences the communication tools to connect seamlessly with their audiences, clear, accurate, and life-changing medical information can reach the people who need it most.

Let us partner with you and help you transform the way you communicate.